Instil Bio Inc (TIL) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access TIL quarterly Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Instil Bio Inc adapts its cash strategy across cycles.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-71.37
Depreciation & amortization0.53
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges15.62
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation8.69
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total-0.48
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest-
Income taxes0.00
Increase (Decrease) in Accrued Investment Income Receivable-3.40
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.12
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets6.12
Other Working Capital0.35
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities10.99
Discontinued operations0.00
Net Cash flow from Operating Activities-36.62
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.43
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities135.90
Payments to Acquire Available-for-sale Securities, Debt-100.86
Real Estate Investments0.00
Sales Of Held For Trading Investments Net-
Proceeds From Sale Of Mineral Properties-
Development Costs Capitalization-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development-10.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities25.48
Financing Activities
Short-term debt Net-0.17
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock7.46
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.29
Effect of exchange rate on cash flow0.02
Discontinued operations0.00
Free Cash Flow-36.19
Total Cash Flow-3.85
4 historic quarters locked

Sign in to unlock the full Instil Bio Inc cash flow history.

About Instil Bio Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 27, 2026
  • Source: til-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001789769-26-000019

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License